Related Experiment Video
Updated: Jun 8, 2026
09:32
Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
Published on: April 13, 2017
Striatal pathology underlies prion infection-mediated hyperactivity in mice
Keith M Gunapala1, Daniel Chang, Cynthia T Hsu
1Division of Biology, California Institute of Technology, Pasadena, CA, USA.
Prion
|October 16, 2010
Summary
Prion diseases in mice show hyperactivity linked to striatal pathology. Pathological markers, not neurotransmitters, are key for diagnosing these mouse models of prion disease.
Area of Science:
- Neuroscience
- Prion Disease Research
- Animal Models
Background:
- Prion diseases are challenging to study in mouse models due to strain diversity and complex assessments.
- Understanding behavioral and neuropathological changes is crucial for advancing prion disease research.
Purpose of the Study:
- To compare behavioral and neuropathological outcomes of different prion strains in C57BL/6J mice.
- To identify sensitive markers for diagnosing prion disease in murine models.
Main Methods:
- Utilized a home cage behavior detection system to monitor mouse activity.
- Conducted systematic studies of pathological markers (IBA1, GFAP, degeneration) and neurotransmitter systems (serotonin, dopamine, noradrenalin, acetylcholine).
Main Results:
- RML and 139A prion strains induced significant hyperactivity.
- Early striatal pathology was observed in mice infected with RML or 139A prions, but not 22L prions.
- Neurotransmitter systems showed minimal decline, with a slight decrease in dorsal striatal dopaminergic innervation.
Conclusions:
- The dorsal striatum plays a role in the hyperactivity observed in RML and 139A prion-infected mice.
- Home cage activity measurements may serve as a sensitive diagnostic tool for murine prion diseases.
- Pathological stains are more informative than neurotransmitter markers for prion disease detection in mouse models.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...